We have all had multiple viral infections in our lifetime, be it the flu or a more serious disease such as measles. Every year, new strains of virus feature in the spot light, making it a challenge to keep up with treatment options. But when did we first come across viruses? How did we differentiate them from other disease-causing pathogens? How did the first vaccinations against viruses come about?
On 31st August 2018, I attended the protein disulphide bonds- biochemistry, biotechnology and biomedical impact conference organised by the Biochemical society at the university of Kent. I am a research fellow working on Alzheimer’s disease (AD) and more specifically on tau protein, which is associated with the pathogenesis of the disease.
In this blog Melissa talks about her experience developing and piloting a science outreach activity funded by the Biochemical Society.
By Peter Wotherspoon, Biochemical Society
Okay, so we all know how this song and dance goes; it’s been in enough movies by this point. Here we have (under slightly more violent circumstances than would be ideal) what is generally thought of as the technological singularity. The idea that the creation of artificial super-intelligence will lead to an unstoppable cascade of technological advancements because no doubt a computer intelligence smarter than us can in turn make another computer intelligence smarter than it and so on. So, with all the hype around AI recently, have we reached the tipping point?